One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Crohn’s Disease of the Ileoanal Pouch: A High Rate of Potential Overdiagnoses Open Access
doi : 10.1093/ibd/izad228
Volume 30, Issue 10, October 2024
Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study Open Access
doi : 10.1093/ibd/izae064
Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study Free
doi : 10.1093/ibd/izad217
Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN Free
doi : 10.1093/ibd/izad218
KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn’s Disease Free
doi : 10.1093/ibd/izad214
Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn’s Disease Exhibit Similar Pharmacokinetics Free
doi : 10.1093/ibd/izad307
Appearance of the Bowel and Mesentery During Surgery Is Not Predictive of Postoperative Recurrence After Ileocecal Resection for Crohn’s Disease: A Prospective Monocentric Study Free
doi : 10.1093/ibd/izad227
Are Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease? Free
doi : 10.1093/ibd/izad246
Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort Open Access
doi : 10.1093/ibd/izad242
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn’s Disease: A Retrospective, International Multicenter Study Free
doi : 10.1093/ibd/izad248
Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study Free
doi : 10.1093/ibd/izad256
Crohn’s Disease Mortality and Ambient Air Pollution in New York City Free
doi : 10.1093/ibd/izad243
Incidental Dysplasia During Total Proctocolectomy With Ileoanal Pouch: Is It Associated With Worse Outcomes? Free
doi : 10.1093/ibd/izad263
An Insight into Patients’ Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts Open Access
doi : 10.1093/ibd/izad247
Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years Free
doi : 10.1093/ibd/izad253
Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn’s Disease Free
doi : 10.1093/ibd/izad251
Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY Open Access
doi : 10.1093/ibd/izad245
Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis Free
doi : 10.1093/ibd/izad250
Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men Free
doi : 10.1093/ibd/izad266
Childhood Socioeconomic Characteristics and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study Open Access
doi : 10.1093/ibd/izad220
Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study Free
doi : 10.1093/ibd/izad262
Early-Life Hygiene-Related Factors and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study Open Access
doi : 10.1093/ibd/izad257
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn’s Disease Open Access
doi : 10.1093/ibd/izae044
Attenuation of Colitis-Induced Visceral Hypersensitivity and Pain by Selective Silencing of TRPV1-Expressing Fibers in Rat Colon Free
doi : 10.1093/ibd/izae036
Plant-based Diets for Inflammatory Bowel Disease: What Is the Evidence? Free
doi : 10.1093/ibd/izad213
Rates of Endoscopic Recurrence In Postoperative Crohn’s Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis Free
doi : 10.1093/ibd/izad252
The Crohn’s Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions Open Access
doi : 10.1093/ibd/izad255
All-or-Nothing Behavior and Catastrophic Thinking Predict Fatigue in Inflammatory Bowel Disease: A Prospective Cohort Study Open Access
doi : 10.1093/ibd/izad193
Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study Free
doi : 10.1093/ibd/izad191
In Acute Severe Ulcerative Colitis Patients Who Receive Rescue Therapy, Prior Maintenance Therapy and Day 3 C-Reactive Protein After Rescue Therapy Are Associated With 12-Month Colectomy Risk Free
doi : 10.1093/ibd/izad215
Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease
doi : 10.1093/ibd/izae105
Cancer Screening in Patients With Inflammatory Bowel Disease: Don’t Forget the Anus! Free
doi : 10.1093/ibd/izad267
Machine Learning and Radiomics: Changing the Horizon of Crohn’s Disease Assessment Free
doi : 10.1093/ibd/izad284
Correction to: Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study Free
doi : 10.1093/ibd/izae134
Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
doi : 10.1093/ibd/izae130
In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis
doi : 10.1093/ibd/izae183
Reply: In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis
doi : 10.1093/ibd/izae181
